📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Paloma Pharmaceuticals

1.1 - Company Overview

Paloma Pharmaceuticals Logo

Paloma Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of early-stage drug development focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway, including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), and CNS (epilepsy and neurodegenerative).

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Paloma Pharmaceuticals

Cullgen Logo

Cullgen

HQ: United States Website
  • Description: Provider of drug discovery services leveraging its uSMITE platform to develop targeted protein degraders using novel E3 ligands for diseases lacking effective therapies, including cancer, inflammation, autoimmune, and neurodegenerative disorders; pipeline includes CG001419, an orally bioavailable pan-TRK degrader in phase I/II clinical trial for solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cullgen company profile →
Exzell Pharma Logo

Exzell Pharma

HQ: Canada Website
  • Description: Provider of medicines, healthcare and biopharma-based products, including EsopH OTC therapy for GERD that relieves heartburn and can be used with PPI prescriptions; Swiss Natural vitamins, supplements and minerals from natural sources; Salinex nasal spray to hydrate and cleanse; PediaVit vitamins and iron for infants and children; Koena multi-strain probiotics; and Ozonol ointment for scrapes, minor burns, and skin irritations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exzell Pharma company profile →
PharmAkea Logo

PharmAkea

HQ: United States Website
  • Description: Provider of biopharmaceutical R&D, developing high-quality small molecule drug candidates against protein targets involved in fibroproliferative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PharmAkea company profile →
Sanofi Logo

Sanofi

HQ: France Website
  • Description: Provider of prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases, offering research, development, manufacturing, and marketing of innovative therapeutic solutions across diabetes care, human vaccines, innovative drugs, consumer healthcare (OTC for allergies, cough, cold, flu, digestive wellness), pain care, physical & mental wellness, patient engagement, emerging markets, animal health, and the new G enzyme.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sanofi company profile →
Amerita Logo

Amerita

HQ: United States Website
  • Description: Provider of specialty infusion services focused on delivering complex pharmaceutical products and clinical services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amerita company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Paloma Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Paloma Pharmaceuticals

2.2 - Growth funds investing in similar companies to Paloma Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Paloma Pharmaceuticals

4.2 - Public trading comparable groups for Paloma Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Paloma Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Paloma Pharmaceuticals

What does Paloma Pharmaceuticals do?

Paloma Pharmaceuticals is a provider of early-stage drug development focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway, including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), and CNS (epilepsy and neurodegenerative).

Who are Paloma Pharmaceuticals's competitors?

Paloma Pharmaceuticals's competitors and similar companies include Cullgen, Exzell Pharma, PharmAkea, Sanofi, and Amerita.

Where is Paloma Pharmaceuticals headquartered?

Paloma Pharmaceuticals is headquartered in United States.

How many employees does Paloma Pharmaceuticals have?

Paloma Pharmaceuticals has 1,000 employees 🔒.

When was Paloma Pharmaceuticals founded?

Paloma Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Paloma Pharmaceuticals in?

Paloma Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Paloma Pharmaceuticals

Who are the top strategic acquirers in Paloma Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Paloma Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Paloma Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Paloma Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Paloma Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Paloma Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Paloma Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Paloma Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Paloma Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Paloma Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Paloma Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Paloma Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Paloma Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Paloma Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Paloma Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Paloma Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Paloma Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Paloma Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Paloma Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Paloma Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Paloma Pharmaceuticals